GCM
AVNS

Graham Capital Management’s Avanos Medical AVNS Stock Holding History

Graham Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,711
Closed -$478K – 1011
2023
Q2 		$478K Sell
18,711
-9,155
-33% -$241K 0.01% 569
2023
Q1 		$829K Sell
27,866
-16,145
-37% -$469K 0.03% 586
2022
Q4 		$1.19M Sell
44,011
-5,459
-11% -$133K 0.04% 465
2022
Q3 		$1.08M Buy
49,470
+9,113
+23% +$238K 0.04% 452
2022
Q2 		$1.1M Buy
40,357
+13,254
+49% +$381K 0.04% 406
2022
Q1 		$907K Buy
27,103
+12,912
+91% +$416K 0.03% 345
2021
Q4 		$492K Buy
+14,191
New +$459K 0.02% 175

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Graham Capital Management's AVNS Position: Q3 2023 in Review

Graham Capital Management sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 18,711 shares — an estimated $478K sold.

Graham Capital Management first reported a position in AVNS in Q4 2021 and held it in 7 quarters. The position peaked at $1.19M in Q4 2022. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

  • Graham Capital Management reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
  • Graham Capital Management sold 18,711 Avanos Medical shares in Q3 2023, an estimated $478K.
  • Graham Capital Management first reported a position in Avanos Medical in Q4 2021 and held it in 7 quarters.
  • Graham Capital Management's Avanos Medical position peaked at $1.19M in Q4 2022.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on Graham Capital Management's 13F filing for Q3 2023, filed 22 Nov 2023.